5 of the 7 Patients Participating in Compassionate Investigational New Drug (IND) Program

  • Twelve patients were initially approved for the U.S. Government Food & Drug Administration's Investigational New Drug (IND) Compassionate Access Program.


  • Five have since died, all from AIDS-related complications.


  • There are currently seven patients still receiving regular legal Med. MJ from the U.S. government; two patients wish to remain anonymous.


  • The Marijuana distributed to these patients is grown at the University of Mississippi under administration by the National Institute on Drug Abuse (NIDA).


  • A clinical study examining the overall health of 4 of the remaining 7 patients was published in the January 2002 issue of The Journal of Cannabis Therapeutics. It demonstrated "clinical effectiveness in these patients in treating glaucoma, chronic musculoskeletal pain, spasm and nausea, and spasticity of multiple sclerosis."
The remaining five patients, per Al Byrne of the non-profit group Patients Out of Time, are:

No. Name of Patient Diagnosis Date Entered IND Program Marijuana Dosage Years in Program
(through 12/31/01)
(as of 2/28/02)
1 Douglass, Barbara Multiple Sclerosis August 30, 1991 Nine cured ounces (of MJ) per month 10 Still Receives Med MJ
2 McMahon, George Nail Patella Syndrome March 16, 1990 Eight cured ounces (of MJ) per month 11 Still Receives Med MJ
3 Millet, Corrine Glaucoma November 16, 1990 Four cured ounces (of MJ) per month 12 Still Receives Med MJ
4 Musikka, Elvy Glaucoma October 17, 1988 Eight cured ounces (of MJ) per month 13 Still Receives Med MJ
5 Rosenfeld, Irvin Rare Bone Disorder November 20, 1982 Eleven cured ounces (of MJ) every three weeks 19 Still Receives Med MJ

6 Name Withheld
by Request
Unknown Unknown Unknown Unknown Unknown
7 Name Withheld
by Request
Unknown Unknown Unknown Unknown Unknown